Introduction
Chronic kidney disease (CKD) is a disease that has been present for months to years. Chronic renal disease (CRD), chronic renal failure (CRF), and chronic renal insufficiency refer to the same condition. CKD is not a single disease. When an individual has a diagnosis of CKD, there is nephron dysfunction that persists three months or longer resulting in irreversible kidney damage. More often kidney function worsens over a number of years. By the time the signs of CKD revealed, the damage is severe. There is no cure for CKD. The remaining nephrons are working so hard that with time they will fail as well. CKD is usually fatal in months to years but various treatments can keep the people comfortable and with a good quality of life for months to years. CKD epidemiology shows more in the developing countries than in the developed one. An incidence of CKD increases with age (Iseki et al., 1993) . Patients with renal failure are susceptible to infection. In the predialysis era, 60% of patients with chronic renal failure requiring hospitalization were infected and 39% died from infectious causes. It was assumed that the debility caused by the uremic state increased the risk of infection, and the reversal of uremia would reduce the risk of infection (Berman, 2004) .
Haemodialysis (HD) is a medical procedure to filter the wastes from the blood and to retain the normal constituents of the blood by a special dialysis machine. HD is frequently done with end stage of chronic renal failure. HD procedure disturbances in both innate (Muniz-Junqueira et al. People with CKD may be more susceptible to infection. It is recommended that they get the vaccinations for Hepatitis B and A, Influenza, H1N1 (swine flu), HIV and Some Bacteria like Pneumococcus. Worldwide, about 170 million people are infected by the hepatitis C virus (HCV). Infection is much more common in patients with chronic kidney disease (CKD) than in the general population. Infection with the hepatitis C virus (HCV) is an unsolved public health problem. One reason for this is that infection with HCV can cause kidney disease. Another reason is that the virus is transmitted through contact with blood and can be passed between patients in dialysis units if the correct hygienic precautions are not followed. Before it was possible to screen for HCV, many CKD patients were infected through blood transfusions (KDIGO, 2009). In Europe its incidence ranges from 0.2% to 3.5% (Esteban et al., 2008) . Cavoli et al., (2011) explained the Hepatitis C virus (HCV) infection is a never-ending public health problem. Many studies have investigated the incidence of HCV infection among dialysis patients, but there have only been a few epidemiological studies in renal conservative therapy. They studied 320 subjects with pre-dialysis chronic kidney disease living in Sicily, Italy. The incidence of HCV infection was 6.25%. In Europe, incidence ranges from 0.2% to 3.5%. It appears that the incidence of HCV infection is higher in the studied patient population than in the population as a whole.
Kidney disease is an important complication of human immunodeficiency virus (HIV) infection. Kidney function is abnormal in up to 30% of HIV-infected patients, AIDSrelated kidney disease has become a relatively common cause of end-stage renal disease (ESRD) requiring dialysis, and kidney disease may be associated with progression to AIDS and death (Gupta et al., 2004) .
The aim of this study is to assess the occurrence of different viral infection in CKD patients of Haemodialysed patients at Al-khoms teaching hospital, Al-khoms, Libya. People with CKD/ESRD may be more susceptible to infection. Result of present study revealed that there is no HIV infection (Table 1) of Haemodialysis cases in al-khoms teaching Hospital, Al-khoms. This result depicts the Life style of people in Libya. All HD patients should be tested for HIV since prompt diagnosis, monitoring and timely initiation of Highly Active Anti-Retroviral Therapy (HAART) consisted of three or more highly potent anti-HIV drugs, commonly reverse transcriptase inhibitors and protease inhibitors, improves prognosis (Vardinon et al., 1999) .
HBV infections are found in 2 female cases (1 in age between 1 and 20 years and the other one in the age between 41 and 60 years old) ( (Lavanchy, 2004) . Consequently, most HD units treat chronic HBV carriers. Interestingly, because of the known acquired immunity disturbances in this population, after the initial HBV infection, 60% of haemodialysis patients become chronic carriers, while the respective percentage in the general population is only 5% (London et al., 1977) . Vaccination against HBV is also an effective measure, since vaccinated patients have 70% less possibility to become HBV carriers (Miller et al., 1999) .
Result of HCV indicates that there are 6 positive cases from the 71 cases (Table 3) . Five HCV infection patients are observed in both male (3 cases) and female (2 cases) of the same age between 41 and 60 years old (Table 3 ) and another one male case is observed in the age between 61 and 80 years old. Fabrizi et al., (2004) explained that the infection of HBV and HCV are the most common in the patients with liver disease. Gioacchino et al., (2011) also informed that HCV infection is a never-ending public health problem among HD patients. There are about 170 million hepatitis C virus (HCV) carriers worldwide and HD patients belong to a high-risk population (Yen et al., 2003) . A meta-analysis revealed that in HD patients' HCV carriage is associated with 1.57 times increased risk of death. Liver cirrhosis and hepatoma contribute to the increased mortality (Fabrizi et al., 2004) . The routine ribavirin treatment show adverse effect. The only available treatment for HCV infection with HD patient is interferon A with more than or equal to 30,00,000 units 3times a week (Gordon et al., 2008 ).
Conclusion
Generally viral infections are more in HD and transplant cases. But in this study no HIV is reported and few cases of HBV and HCV are found out. The chances of infection of the vascular access are increased in patients with poor personal hygiene, malnutrition and inadequate dialysis. Prevention of infection is one of the few avenues available to reduce hospitalizations, control costs, and improve quality of life for these patients. 
